Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serotonin-releasing agents with reduced off-target effects.
Mayer FP, Niello M, Cintulova D, Sideromenos S, Maier J, Li Y, Bulling S, Kudlacek O, Schicker K, Iwamoto H, Deng F, Wan J, Holy M, Katamish R, Sandtner W, Li Y, Pollak DD, Blakely RD, Mihovilovic MD, Baumann MH, Sitte HH. Mayer FP, et al. Among authors: baumann mh. Mol Psychiatry. 2023 Feb;28(2):722-732. doi: 10.1038/s41380-022-01843-w. Epub 2022 Nov 9. Mol Psychiatry. 2023. PMID: 36352123 Free PMC article.
Reply to "Letter to the Editor regarding 'Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone'".
Levinstein MR, De Oliveira PA, Casajuana-Martin N, Quiroz C, Budinich RC, Rais R, Rea W, Ventriglia EN, Llopart N, Casadó-Anguera V, Moreno E, Walther D, Glatfelter GC, Weinshenker D, Zarate CA Jr, Casadó V, Baumann MH, Pardo L, Ferré S, Michaelides M. Levinstein MR, et al. Among authors: baumann mh. Mol Psychiatry. 2024 Dec 6. doi: 10.1038/s41380-024-02864-3. Online ahead of print. Mol Psychiatry. 2024. PMID: 39639176 No abstract available.
Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy-N,N-dimethyltryptamine Analogs in Mice.
Glatfelter GC, Clark AA, Cavalco NG, Landavazo A, Partilla JS, Naeem M, Golen JA, Chadeayne AR, Manke DR, Blough BE, McCorvy JD, Baumann MH. Glatfelter GC, et al. Among authors: baumann mh. ACS Chem Neurosci. 2024 Dec 18;15(24):4458-4477. doi: 10.1021/acschemneuro.4c00513. Epub 2024 Dec 5. ACS Chem Neurosci. 2024. PMID: 39636099
Characterization of novel nitazene recreational drugs: Insights into their risk potential from in vitro µ-opioid receptor assays and in vivo behavioral studies in mice.
Vandeputte MM, Glatfelter GC, Walther D, Layle NK, St Germaine DM, Ujváry I, Iula DM, Baumann MH, Stove CP. Vandeputte MM, et al. Among authors: baumann mh. Pharmacol Res. 2024 Dec;210:107503. doi: 10.1016/j.phrs.2024.107503. Epub 2024 Nov 7. Pharmacol Res. 2024. PMID: 39521025 Free article.
Reinforcing effects of fentanyl analogs found in illicit drug markets.
Maitland AD, McGriff SA, Glatfelter GC, Schindler CW, Baumann MH. Maitland AD, et al. Among authors: baumann mh. Psychopharmacology (Berl). 2024 Nov;241(11):2375-2383. doi: 10.1007/s00213-024-06641-6. Epub 2024 Jul 5. Psychopharmacology (Berl). 2024. PMID: 38965085 Free PMC article.
314 results